You are currently viewing a new version of our website. To view the old version click .

Oncology: State-of-the-Art Research in Austria

This special issue belongs to the section “Cancer Therapy“.

Special Issue Information

Dear Colleagues,

Cancer remains one of the leading causes of death worldwide. Austrian scientists were among the pioneers in cancer research, and today, the scientific output of our small country is internationally acknowledged. Furthermore, the clinical outcome of cancer patients in our country is among the best worldwide, and thus Austrian clinicians and scientists can look back on a great history and forward to a promising future. In the present Special Issue, we want to focus on modern Austrian cancer research in times of personalized and multimodal medicine. Nationwide and international collaborations will be our focus. All types of research, from basic to translational to clinical, as well as relevant review articles summarizing state-of-the-art knowledge, are welcome for submission. The full spectrum of cancer research and malignant diseases will be considered for publication. Also, historic articles looking back to the past of Austrian cancer research are welcome for submission. This Special Issue provides a platform to present the high quality of research and standard of care for the Austrian cancer research community.

Dr. Bahil Ghanim
Dr. Mir Alireza Hoda
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oncology
  • cancer
  • research
  • tumor
  • Austria

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694